PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Glucosamine - Osteoarthritis
PAD Profile : Glucosamine - Osteoarthritis
Keywords :
chondroitin, nutraceutical, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value, joint supplements, health supplements
Brand Names Include :
Arthriex, Dolenio, Glusartel, Yointy
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Piroxicam
- Other health supplement preparations
- Capsaicin
- Ibuprofen
- Ketoprofen
- Diclofenac sodium
- Felbinac
Other Indications
Additional Documents
Type
Document
Review Date
Patient resource
01 January 2021
Committee Recommendations
Date
Committee Name
Narrative
22 January 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Prescribing Clinical Network does not recommend the use of glucosamine and chondroitin
Glucosamine and chondroitin will be considered BLACK on the traffic light system and prescribers should:
- NOT initiate glucosamine and chondroitin in any new patients AND
- De-prescribe glucosamine and chondroitin in all patients, in line with NHS England guidance.
Associated BNF Codes
09. Nutrition and Blood
09.12.00. Other health supplements